1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with Ovarian Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cabot, MC; Gupta, V; Jazwinski, SM; Liu, YY; Patwardhan, GA; Zhang, QJ | 1 |
| Aoki, D; Isonishi, S; Iwamori, M; Kiguchi, K; Mikami, M; Takada, H; Tanaka, K | 1 |
2 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and Ovarian Neoplasms
| Article | Year |
|---|---|
Direct quantitative determination of ceramide glycosylation in vivo: a new approach to evaluate cellular enzyme activity of glucosylceramide synthase.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Cell Line, Tumor; Cell Membrane Permeability; Ceramides; Chromatography, Thin Layer; Colonic Neoplasms; Enzyme Assays; Enzyme Inhibitors; Female; Glucosyltransferases; Glycosylation; Humans; Injections, Intralesional; Mice; Mice, Nude; Morpholines; Oligonucleotides; Ovarian Neoplasms; Random Allocation; Reproducibility of Results; Xenograft Model Antitumor Assays | 2010 |
Possible involvement of glycolipids in anticancer drug resistance of human ovarian serous carcinoma-derived cells.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma; Cell Line, Tumor; Cell Survival; Cholesterol; Cisplatin; Drug Resistance, Neoplasm; Female; Glycolipids; Glycosyltransferases; Humans; Inhibitory Concentration 50; Morpholines; Multidrug Resistance-Associated Proteins; Ovarian Neoplasms; Paclitaxel; Phospholipids; Sialyltransferases | 2012 |